validation of analytical methods rutendo kuwana training workshop: assessment of interchangeable...
TRANSCRIPT
Validation of analytical methods
Rutendo Kuwana
Training workshop: Assessment of Interchangeable Multisource Medicines, Kenya, August 2009
Assessment of Interchangeable Multisource Medicines, Kenya, August 20092 | 2
BACKGROUND-LAB METHOD FLOWBACKGROUND-LAB METHOD FLOW
MethodValidation
MethodTransfer
MethodDevelopment
Approved
Assessment of Interchangeable Multisource Medicines, Kenya, August 20093 | 3
VALIDATIONVALIDATION
“ THE PROCESS OF PROVIDING DOCUMENTED EVIDENCE THAT SOMETHING DOES WHAT IT IS
INTENDED TO DO”
Assessment of Interchangeable Multisource Medicines, Kenya, August 20094 | 4
WHY VALIDATE?WHY VALIDATE?
To demonstrate that the method is suitable for its intended use
Provides assurance of reliability
Assessment of Interchangeable Multisource Medicines, Kenya, August 20095 | 5
WHO GMP - 4.11 Analytical methods, computers and cleaning proceduresWHO GMP - 4.11 Analytical methods, computers and cleaning procedures
“It is of critical importance that particular attention is paid to the validation of analytical test methods, automated systems and cleaning procedures.”
Validation of analytical procedures used in the examination of pharmaceutical materials (WHO Expert Committee on Specifications for Pharmaceutical Preparations. 32nd Report. Geneva, WHO, 1992 (WHO Technical Report Series, No. 823)
Text on Validation of Analytical Procedures Q2 (R1) Validation of Analytical Procedures: Text and Methodology. ICH Harmonized Tripartite Guidelines
Assessment of Interchangeable Multisource Medicines, Kenya, August 20096 | 6
ANALYTICAL METHOD VALIDATION PERFORMANCE CHARACTERISTICSANALYTICAL METHOD VALIDATION PERFORMANCE CHARACTERISTICS
Range
System Suitability
MethodValidation
Precision
Accuracy
Limit of Detection
Limit of Quantitation
Specificity
Linearity
Robustness
Range
System Suitability
MethodValidation
Precision
Accuracy
Limit of Detection
Limit of Quantitation
Specificity
Linearity
Robustness
Assessment of Interchangeable Multisource Medicines, Kenya, August 20097 | 7
TYPES OF ANALYTICAL METHODS TO BE VALIDATED
TYPES OF ANALYTICAL METHODS TO BE VALIDATED
Identification tests
Quantitative tests for impurities’ content
Limit tests for the control of impurities
Quantitative tests of the active in samples of the drug substance (raw material), finished product or other selected components in the drug
Assessment of Interchangeable Multisource Medicines, Kenya, August 20098 | 8
ACCURACY ACCURACY
Expresses the CLOSENESS of agreement BETWEEN the value, which is accepted either as a conventional TRUE VALUE or an accepted REFERENCE VALUE and the VALUE FOUND i.e. individual observation or mean of measurements
The closeness of test results to the
true value obtained by the method
(trueness).
– Established across the range
Assessment of Interchangeable Multisource Medicines, Kenya, August 20099 | 9
DETERMINATION OF ACCURACYDETERMINATION OF ACCURACY
Drug Substance
– Analysis of reference material
– Compare results to a second, well-characterized method
Drug Product
– Analysis of synthetic mixtures spiked with known quantities of
components
– Compare results to a second, well-characterized method
Determined concurrently with precision, linearity and specificity
Assessment of Interchangeable Multisource Medicines, Kenya, August 200910 | 10
DETERMINATION OF ACCURACY cont’DETERMINATION OF ACCURACY cont’
Impurities (Quantitation)
– Analysis of samples (Drug substances/Drug product) spiked with known
amounts of impurities
– If impurities are not available, see specificity
Recommended Data
– Minimum of 9 determinations over a minimum of 3 concentration levels
covering the specified range (e.g. 3 concentrations/3 replicates each)
– Reported as % recovery of known added amount or difference between
the mean and true value, with confidence intervals
Assessment of Interchangeable Multisource Medicines, Kenya, August 200911 | 11
PRECISIONPRECISION
Precision
– The measure of the degree of
agreement (degree of scatter)
among test results when the
method is applied repeatedly
to multiple samplings of a
homogeneous sample
– Expressed as %RSD for a
statistically significant number
of samples
Assessment of Interchangeable Multisource Medicines, Kenya, August 200912 | 12
Precision (of any process)Precision (of any process)
The precision (VARIABILITY) of an analytical procedure is usually expressed as the standard deviation (S), variance (S2), or coefficient of variation (= relative standard deviation, R.S.D.) of a series of measurements.
The confidence interval should be reported for each type of precision investigated.
Measured mean Real meanMeasured mean Real mean
Assessment of Interchangeable Multisource Medicines, Kenya, August 200913 | 13
PRECISION cont’PRECISION cont’
May be considered at 3 levels: – Repeatability, a measure of variability under the same
operating conditions over a short interval (intra-assay precision). Minimum of 9 determinations covering specified range
– Intermediate precision, a measure of within-laboratory variations (different days, different analysts, different equipment)
– Reproducibility, expresses precision between laboratories (e.g. in collaborative studies), also applies to method transfer
Assessment of Interchangeable Multisource Medicines, Kenya, August 200914 | 14
Repeatability (of any process)Repeatability (of any process)
Repeatability expresses the precision (spread of the data, variability) under the same operating conditions over a short interval of time. Repeatability is also termed intra-assay precision.
Measured meanMeasured mean
Assessment of Interchangeable Multisource Medicines, Kenya, August 200915 | 15
Intermediate Precision and Reproducibility
Intermediate Precision and Reproducibility
Intermediate precision expresses within-laboratories variations. #1, #2 and #3: different days, different analysts, different (manufacturing) equipment, etc.
Reproducibility expresses the precision between laboratories #1, #2 and #3 (collaborative studies, usually applied to standardization of methodology). (Transfer of technology)
Measured meansMeasured means
Assessment of Interchangeable Multisource Medicines, Kenya, August 200916 | 16
ACCURACY & PRECISIONACCURACY & PRECISION
Inaccurate &imprecise
Inaccurate butprecise
Accurate butimprecise Accurate and precise
Assessment of Interchangeable Multisource Medicines, Kenya, August 200917 | 17
SPECIFICITY/SELECTIVITYSPECIFICITY/SELECTIVITY
– The ability to measure accurately and
specifically the analyte in the presence of
components that may be expected to be
present in the matrix
– The degree of interference
• Active Ingredients
• Excipients
• Impurities (synthetic precursors, enantiomers)
• Degradation Products
• Placebo Ingredients
Assessment of Interchangeable Multisource Medicines, Kenya, August 200918 | 18
SPECIFICITY/SELECTIVITYSPECIFICITY/SELECTIVITY
• Combination of 2 or more analytical procedures may be
required to achieve necessary level of discrimination
• Stability indicating analytical methods should always be
specific
• Analysts should ascertain whether the peaks within a sample
chromatogram are pure or consist of more than one compound.
Therefore should know how many compounds are in the
sample or use procedures to detect peak purity
Assessment of Interchangeable Multisource Medicines, Kenya, August 200919 | 19
LOD, LOQ and SNRLOD, LOQ and SNR
Limit of Quantitation (LOQ)
Limit of Detection (LOD)
Signal to Noise Ratio (SNR)
noise
Peak ALOD
Peak BLOQ
Baseline
Assessment of Interchangeable Multisource Medicines, Kenya, August 200920 | 20
LIMIT OF DETECTIONLIMIT OF DETECTION
The lowest concentration of an analyte in a sample that can be detected, not quantified
Expressed as a concentration at a specified signal:noise ratio
Assessment of Interchangeable Multisource Medicines, Kenya, August 200921 | 21
LIMIT OF QUANTIFICATIONLIMIT OF QUANTIFICATION
The lowest concentration of analyte in a sample that can be determined with acceptable precision and accuracy under stated operational conditions
Expressed as concentration of analyte
Assessment of Interchangeable Multisource Medicines, Kenya, August 200922 | 22
LINEARITYLINEARITY
– The Ability of the method to obtain test results that are directly
proportional to concentration within a given range
– Method: dilution of stock solution/separate weighings
– Expressed as the variance of the slope of the regression line
– Correlation coefficient, y-intercept, slope of regression line and
residual sum of squares should be presented together with plot of
the data
Assessment of Interchangeable Multisource Medicines, Kenya, August 200923 | 23
LinearityLinearity
Linearity expresses differences in precision at different points of a given range.
The linearity of an analytical procedure is its ability (within a given range) to obtain test results, which are directly proportional to the
concentration (amount) of analyte in the sample
Assessment of Interchangeable Multisource Medicines, Kenya, August 200924 | 24
RANGERANGE
– Interval between upper and lower levels of analyte demonstrated
by the method
– Confirms that the analytical procedure provides acceptable
degree of linearity, accuracy and precision when applied to
samples containing amounts of analyte within or at the extremes
of the specified range
– Minimum 5 concentrations
Assessment of Interchangeable Multisource Medicines, Kenya, August 200925 | 25
Range (minimum requirements)Range (minimum requirements)
Assay of an API or a FPP: ± 20% of the test concentration.
Content uniformity: ± 30% of the test concentration (unless a wider more appropriate range, based on the nature of the dosage form (e.g., metered dose inhalers), is justified).
Dissolution testing: ± 20 % over the specified range.
Impurity: from the reporting level of an impurity to 120% of the specification. (Unusually potent or toxic impurities, LOD and LOQ should be commensurate with ICH requirement.)
If assay and purity are performed together as one test and only a 100% standard is used, linearity should cover the range from the reporting level of the impurities to 120% of the assay specification
Assessment of Interchangeable Multisource Medicines, Kenya, August 200926 |
Typical expected results for Analyte concentration vs. Precision(The AOAC manual for the Peer-Verified Methods program)
Typical expected results for Analyte concentration vs. Precision(The AOAC manual for the Peer-Verified Methods program)
Analyte Conc (%)Analyte RatioUnitRSD%
1001100%1.3
1010-110%2.8
110-21 %2.7
0.110-30.1%3.7
0.0110-4100 ppm5.3
0.00110-510 ppm7.3
0.000110-61 ppm11
0.0000110-7100 ppb15
0.00000110-810 ppb21
0.000000110-91 ppb30
Assessment of Interchangeable Multisource Medicines, Kenya, August 200927 | 27
RUGGEDNESSRUGGEDNESS
Ruggedness
– Degree of reproducibility of test
results under a variety of
conditions
• Different Analysts
• Different Laboratories
• Different Instruments
• Different Reagents
• Different Days
• Etc.
– Expressed as %RSD
Assessment of Interchangeable Multisource Medicines, Kenya, August 200928 | 28
ROBUSTNESSROBUSTNESS
Measure of the capacity to
remain unaffected by small
(deliberate) variations in
method parameters
– Indication of reliability
during normal use
Assessment of Interchangeable Multisource Medicines, Kenya, August 200929 | 29
Sensitivity and robustness
Input-output relationship
Assessment of Interchangeable Multisource Medicines, Kenya, August 200930 | 30
Stability of analytical solutionStability of analytical solution
Solutes may readily decompose prior to chromatographic investigations e.g. during sample preparation , extraction, cleanup, phase transfer or storage of prepared vials (refrigerators or automatic sampler). Method development should investigate the stability of the analytes AND standards.
System stability
stability of the samples being analyzed in a sample solution.
Measure of the bias in assay results generated during a preselected time interval e.g. 1 – 48 hours using a single solution
should be determined by replicate analysis of the sample solution.
considered appropriate when the RSD, calculated on the assay results obtained at different time intervals, Less than 20 percent of the corresponding value of the system precision
Assessment of Interchangeable Multisource Medicines, Kenya, August 200931 | 31
SYSTEM SUITABILITYSYSTEM SUITABILITY
The checking of a system, before or during analysis of unknowns, to ensure system performance.
• “No sample analysis is acceptable unless the requirements for system suitability have been met.” (USP Chapter 621)
– Plate Count, Tailing, Resolution
– Determination of reproducibility (%RSD)• For %RSD < 2.0%, Five replicates• For %RSD > 2.0%, Six replicates
System Suitability "Sample“ - A mixture of main components and expected by-products utilized to determine system suitability
“Whenever There is a Significant change in Equipment or Reagents System Suitability Testing Should be Performed” (USP Chapter 621)
Assessment of Interchangeable Multisource Medicines, Kenya, August 200932 | 32
Classes of analytical testsClasses of analytical tests
“The objective of validation of an analytical procedure is to
demonstrate that it is suitable for its intented purpose.”
Class A: To establish identity
Class B: To detect (Bd) and quantitate (Bq) impurities
Class C: To determine quantitatively the concentration, or assay
Class D: To assess characteristics
Other classes not covered in the guides
Assessment of Interchangeable Multisource Medicines, Kenya, August 200933 | 33
Criteria for analytical classesCriteria for analytical classes
CriteriaABqBdCD
AccuracyXXX
PrecisionXXX
RobustnessXXXXX
Linearity and rangeXXX
SpecificityX ?XXXX
Limit of detectionX
Limit of quantitationX
Assessment of Interchangeable Multisource Medicines, Kenya, August 200934 | 34
General requirementsGeneral requirements
Qualified and calibrated instruments
Documented methods
Reliable reference standards
Qualified analysts
Sample integrity
Change control (e.g., synthesis, FPP composition)
Assessment of Interchangeable Multisource Medicines, Kenya, August 200935 | 35
General requirements (2)General requirements (2)
Analytical methods should be used within GMP and GLP environments, and must be developed using the protocols and acceptance criteria set out in the ICH guidelines Q2
(R1)
Assessment of Interchangeable Multisource Medicines, Kenya, August 200936 | 36
General requirements (3)General requirements (3)
Validation Protocol important
Revalidation should accompany
formulation changes (new samples with new compounds or new matrices)
manufacturing batch changes
new analysts with different skills,
new instruments with different characteristics,
new location with different environmental conditions,
new chemicals and/or reference standards and
modification of analytical parameters.
Assessment of Interchangeable Multisource Medicines, Kenya, August 200937 |
Validation ReportValidation Report
Objective and scope of the method (applicability, type).
Summary of methodology.
Type of compounds and matrix.
All chemicals, reagents, reference standards, QC samples with purity, grade, their source or detailed instructions on their preparation.
Procedures for quality checks of standards and chemicals used.
Method parameters.
Critical parameters taken from robustness testing.
Listing of equipment and its functional and performance requirements, e.g., cell dimensions, baseline noise and column temperature range.
Assessment of Interchangeable Multisource Medicines, Kenya, August 200938 |
Validation Report (2)Validation Report (2)
Detailed conditions on conduct of experiments, including sample preparation
Statistical procedures and representative calculations.
Procedures for QC in routine analyses, e.g., system suitability tests.
Representative plots, e.g., chromatograms, spectra and calibration curves.
Method acceptance limit performance data and expected uncertainty of measurement results.
Criteria for revalidation.
The person(s) who developed and validated the method.
References (if any).
Summary and conclusions.
Assessment of Interchangeable Multisource Medicines, Kenya, August 200939 |
Use and Validation of Pharmacopoeial methodsUse and Validation of Pharmacopoeial methods
The degree of validation of a pharmacopoeial method should be adequate for required purpose, and the laboratory be able to match any stated performance data. Following product – specific attributes should be considered
the type of compounds to be analyzed,
matrices,
the type of information required (qualitative or quantitative),
detection and quantitation limits,
Concentration range for analysis based on own product
precision and accuracy (sample preparation critical) as specified by the client of the analytical data and
the type of equipment—its location and environmental conditions.
Therefore PQP three parameters required for PQP – Specificity, Accuracy and Precision
Assessment of Interchangeable Multisource Medicines, Kenya, August 200940 | 40
Main Points AgainMain Points Again
Validation of analytical procedures is a critical requirement in risk assessment and management:
– establishment of product-specific acceptance criteria, and– stability of APIs and FPPs.
Validation should demonstrate that the analytical procedure is suitable for its intented purpose.
HPLC systems and method validation deserves special attention during the inspection of QC laboratories.